Unlocking the potential of antibody-drug conjugates in cervical cancer: emerging targets and clinical trials

Yue Zhang(Guilin Medical University), Yi Gong(University of Electronic Science and Technology of China)
Frontiers in Pharmacology
July 8, 2025
10.3389/fphar.2025.1636120
Cited by 2

Related Papers

ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis
|Journal of Experimental & Clinical Cancer Research|2019|149
Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma
|Experimental & Molecular Medicine|2024|26
Exosome-mediated apoptosis pathway during WSSV infection in crustacean mud crab
|bioRxiv (Cold Spring Harbor Laboratory)|2020|11
Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China
|World Journal of Pediatrics|2023|5